Tuesday, November 24, 09:02 pm IST
| Feedback
Moneycontrol » News Center » Stocks » Brokerage Recommendations
Sun Pharma an outperformer: Karvy
Published on Mon, Jan 12, 2009 at 10:36   |  Updated at Mon, Jan 12, 2009 at 10:42  |  Source : Moneycontrol.com

Karvy Stock Broking has maintained its outperformer rating on Sun Pharmaceutical Industries with a target price of Rs 1300 in its January 12, 2009 research report. "Margins are expected to lower at 42.3 % as compared to 44.1 % in the corresponding quarter in the previous year. PAT is likely to be higher by 39% to Rs 4424 million for the quarter. We have factored the USD 24.5 mn revenue upside from the controlled substances in FY 2010. We marginally upgrade our FY 2010 EPS by 1.3 % to Rs 78.2. We upgrade our price target by 4.3% to Rs 1,300 based on 16.6x FY 2010E. With increasing traction in US markets and domestic formulations on a strong wicket we maintain our Outperformer rating on the stock," says Karvy's research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.


To read the full report click on the attachment......

Attachments : Daily_12-01-09.pdf

Important Links Today:  Leadership Wall    Chat Calendar    The 10 List   
Stock Advice
India Capital Markets
Akshata Deshmukh
Sr Research Analyst
Satish Betadpur
CFA Global Research Director
 
 
 
WHAT OTHERS LIKE
  • Most Read
  • Most Viewed
24 Hours
7 Days
1 Month
©Network 18, 2009. All Rights Reserved